Source: International Congress 2019 – Pleural disease: applying the evidence
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
E. Pitaraki (Larissa, Greece), I. Gerogianni (Larissa, Greece), R. Jagirdar (Larissa, Greece), O. Kouliou (Larissa, Greece), C. Hatzoglou (Larissa, Greece), K. Gourgouliannis (Larissa, Greece), S. Zarogiannis (Larissa, Greece). 2-Deoxy-glucose synergizes with Cisplatin and Pemetrexed chemotherapeutics to reduce cell migration of mesothelioma cells. 3099

Member's Comments

No comment yet.

Related content which might interest you: Effects of Cisplatin and Pemetrexed on the cell viability and cell adhesion of benign mesothelial and mesothelioma cells. Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Interplaying between Gamma-H2AX and autophagy in A549 cells treated with cisplatin and etoposide Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017 Prx1 modulates the chemosensitivity of lung cancer to docetaxel through suppression of FOXO1-induced apoptosis Source: Annual Congress 2012 - New insights in the pathology of lung cancer Year: 2012 The therapeutic efficacy of troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Non-small cell lung cancer treatment: chemotherapy combination gemcitabine – cisplatin – paclitaxel Source: Eur Respir J 2004; 24: Suppl. 48, 302s Year: 2004 Putative cancer stem cells in malignant pleural mesothelioma show resistance to cisplatin and pemetrexed Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Pegylated liposomal doxorubicin compared with traditional doxorubicin in combination chemo-radiotherapy for small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 465s Year: 2002 Effects of 2-Deoxy-glucose (2DG) with cisplatin and pemetrexed in mesothelioma cell mediated collagen gel contraction. Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding Year: 2019 Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 First line treatment with gemcitabine plus cisplatine in non-small cell lung cancer: a comparison with etoposide plus cisplatin Source: Eur Respir J 2005; 26: Suppl. 49, 77s Year: 2005 Deguelin enhances chemosensitivity of non-small cell lung cancer cells Source: Eur Respir J 2006; 28: Suppl. 50, 336s Year: 2006 Docetaxel and carboplatin as the second-line treatment of non-small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 464s Year: 2002 Adaptation to hypoxia leads to apoptosis resistance to cisplatin in non-small cell lung cancer (NSCLC) cell line Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Autophagic cell death of the nutrient deprivation augmented by cytotoxic drugs in lung cancer cell Source: Annual Congress 2009 - Lung cancer biology Year: 2009 Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer Source: Eur Respir J 2006; 27: 1183-1189 Year: 2006 Gemcitabine sensitizes lung cancer cells to Fas /Fas ligand system-mediated killing Source: Annual Congress 2011 - Treatment of lung cancer Year: 2011 The cytotoxic drug melphalan activates respiratory epithelial cells in vitro. Source: Eur Respir J 2002; 20: Suppl. 38, 282s Year: 2002 Asbestos induces doxorubicin resistance in MM98 mesothelioma cells via HIF-1α Source: Eur Respir J 2008; 32: 443-451 Year: 2008 Generating senescent airway epithelial cell populations using low-concentration doxorubicin or etoposide Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 Synergistic effects of anti-her-2/neu antibody and cisplatin in immortalized and primary mesothelioma cell lines Source: Eur Respir J 2002; 20: Suppl. 38, 3s Year: 2002